INTRODUCTION
Angiotensin II receptors are targets for the octapeptide angiotensin II (AII), one of the major components of the reninangiotensin system [1] . They belong to the G-protein-coupled receptor (GPCR) family, characterized by a seven-transmembrane-domain topology. Cloned angiotensin receptors have been classified as AT "
and AT # receptor subtypes on the basis of their G-protein coupling and binding of peptidic and nonpeptidic drugs [2] [3] [4] [5] , with the exception of Xenopus and turkey receptors, which do not fit with this classification [6] . Extensive studies on structure-function relationships on the AT " receptor have already been performed. Molecular modelling and mutagenesis approaches have been widely used to dissect the molecular events underlying recognition of peptide and non-peptide ligands and the process of isomerization between inactive and active conformations involved in receptor activation [7] [8] [9] [10] [11] [12] .
The amino acid sequence of the rat AT " receptor contains three potential sites for N-glycosylation, one at the N-terminus (Asn%) and two on the second extracellular loop (Asn"(' and Asn"))). It has been shown previously that a single mutation of any of these Asn residues preserves angiotensin recognition and hormone-induced inositol phosphate (IP) production [13] . In the present work we report a more complete analysis of the role of glycosylation in rat AT " receptor function through the construction of receptors corresponding to all possible combinations of saccharidic chain suppression. Mutagenesis experiments were performed on a receptor tagged with a peptide epitope. The effects of the mutations on the properties of the receptor were analysed by testing the ligand binding and coupling properties of the receptors, evaluating the molecular mass of the mutated proteins and checking their cellular localization after transfection in COS-7 cells. We demonstrate that : (i) the three potential sites of glycosylation of the rat AT "a receptor are utilized in COS-7 cells ; (ii) their suppression does not significantly affect the ligand binding and coupling properties of the receptor ; (iii) the roles of the various glycosylation sites are not equivalent and specific preservation of one or two of them, according to their localization, is required for the correct delivery of the receptor to the plasma membrane. Furthermore, this work demonstrates that epitope tagging of the AT " receptor is suitable not only for cellular visualization and characterization of the receptor but also for its immunoprecipitation, the latter being a prerequisite for purification of the receptor that will be required in future biochemical or biophysical studies.
MATERIALS AND METHODS

Receptor constructs and site-directed mutagenesis
A sequence encoding 10 amino acids (EQKLISEEDL) of the human c-Myc protein [14] was added at the N-or\and C-termini of the rat AT "a receptor using PCR. In order to reduce the length of the primer encoding the c-Myc-epitope sequence, tagging of the receptor was generated by two steps of amplification with two sets of primers, as described below.
Tagging at the N-terminus
In the first amplification step the primers used were a forward oligonucleotide primer encoding the sequence of the last six amino acids of the c-Myc epitope followed by 21 nucleotides corresponding to amino acids 5-11 of the AT "a receptor, 5h-ATCTCTGAGGAGGACCTGTCTTCTGCTGAAGATGG-TATC-3h (primer 1) and a reverse primer corresponding to nucleotides 526-546 of the AT "a receptor sequence, 3h-TTAT-AGTGTCACACGCGCAAA-5h (primer 2). Primer 1 and primer 2 were used to amplify a 0.55 kb fragment using the AT "a receptor cDNA cloned in the PECE vector [15] as a template. PCR conditions were : 30 cycles at 94 mC for 1 min, 67 mC for 1.5 min, 72 mC for 2 min. The amplified fragment was gel purified and used as a template for a second PCR amplification step using a forward oligonucleotide primer encoding a BglII site followed by an ATG initiation codon, the complete sequence of the c-Myc epitope and the first five nucleotides of the new AT "a receptor sequence, 5h-ACGAAGATCTATGGAGCAGAAGCTGATC-TCTGAGGAGGACCTGTCTTC-3h (primer 3). The reverse primer was primer 2 and PCR conditions were the same as in the first round of amplification. This second amplified fragment was digested with BglII and DraIII sites. The PECE vector containing the cDNA sequence of the AT "a receptor was also digested with BglII and DraIII, gel-purified and the digested PCR fragment was inserted into the linearized plasmid. This construct contained an ATG initiation codon followed by the c-Myc-epitope sequence and the AT "a receptor sequence starting at the fifth amino acid. The first four amino acids were excluded, including Asn%, which belongs to the consensus glycosylation site located at the Nterminus. This construct was named myc-N.
Tagging at the C-terminus
In the first round of amplification, the forward primer corresponded to nucleotides 388-405 of the AT "a receptor cDNA : 5h-ATCGTCCACCCAATGAAG-3h (primer 4). The reverse primer matched the last 27 nucleotides of the AT "a coding sequence, excluding the TGA stop codon (nucleotides 1056-1077), followed by a sequence encoding the first seven amino acids of the c-Myc epitope : 3h-CGGACGCAGAACAAAACTCCACCTCCTCG-TCTTCGACTAAAGGCTC-5h (primer 5). Primers 4 and 5 were used to amplify a 0.72 kb fragment using the AT "a receptor cDNA cloned in the PECE vector as a template. PCR conditions was identical to those used for epitope tagging at the N-terminus. The amplified fragment was gel purified and used as a template for amplification, in conditions as already indicated, with primer 4 as the forward primer and a reverse primer matching the last 24 nucleotides of the fragment followed by the sequence encoding the missing part of the c-Myc-epitope sequence, a stop codon and a sequence encoding an SmaI site, 3h-CTCCTCGTCT-TCGACTAAAGGCTCCTCCTGGACACTGGGCCCCCT-5h (primer 6). The amplified fragment was digested with DraIII and XmaI (isoschizomer of SmaI). The PECE plasmid containing the AT "a receptor sequence was digested with DraIII and XmaI, gelpurified and ligated with the digested amplified fragment. This construct contained the complete AT "a receptor cDNA sequence fused to the c-Myc-epitope sequence at its C-terminus ; it was named myc-C.
The cDNA containing the c-Myc epitope at the N-and Ctermini was obtained by inserting the digested DraIII-SmaI fragment of the PECE-myc-C construct into the PECE-myc-N construct, which was digested with DraIII and XmaI, and gelpurified. It was named myc-N-C.
The chimaeric cDNAs were excised from the PECE plasmid using BglII and XbaI restriction enzymes and subcloned into the BamHI and XbaI sites of the M13mp18 vector. Site-directed mutagenesis was performed by using the oligonucleotide-directed in itro ' sculptor ' mutagenesis system (Amersham). Oligonucleotides that changed Asn for Gln at positions 176 and 188 were 5h-CGCACACTGTGATTTGGGTGTTCTCGATG-3h and 5h-GGGAGCGTCGATTGCCGAGACTCATAAT-3h, respectively. The sequences of the tagged cDNA constructs as well as the successful introduction of mutations were verified by sequencing using the dideoxynucleotide chain-termination method (T7 sequencing kit, Pharmacia Biotech). Wild-type (WT) and mutated receptors were subcloned into the XmaI site of the pCMV vector [16] for expression in COS-7 cells.
Expression of WT and mutated receptors in COS-7 cells
Receptors were transiently expressed in COS-7 cells by using the electroporation transfection method : briefly, 10( cells were resuspended in 300 µl of electroporation buffer (50 mM K # HPO % \20 mM KOH\20 mM CH $ COOK) and incubated for 10 min at room temperature in an electroporation cuvette (0.4-cm electrode gap, Bio-Rad) with 20 µg of pCMV carrier and different amounts of pCMV containing cDNA receptor sequences (0.1-2 µg range). Cells were submitted to an electric discharge (950 mF, 280 V, 50 ms) and cultured for 2 days in Dulbecco's modified Eagle's medium\4.5 g\l glucose\10 % fetal calf serum\ 100 units\ml streptomycin.
Ligand-binding assays
Sarcosine (Sar")-AII (Bachem) was radioiodinated as described previously [17] . 4) ]. After 15 min of preincubation in IP medium containing 10 mM LiCl, cells were incubated for 15 min at 37 mC, in the same medium in the presence or absence of Sar"-AII. Pooled IPs were extracted and measured as described previously [18] .
IP assays
Photoaffinity labelling and immunoblotting analysis
Photoaffinity labelling of WT and mutated receptors COS-7 cells grown on 15-cm plates were washed twice with PBS and incubated in the dark for 4 h at 4 mC in binding buffer containing 3 nM ["#&I]Sar",(4h-N $ )Phe)-AII [19] in the presence or absence of 5i10 −( M Sar"-AII. Cells were washed twice with PBS\5 mM MgCL # (pH 7.4). Then the medium was removed and the cell layer was irradiated with UV light (254 nm) for 7 min on ice. Photolysed cells were scraped with a rubber policeman in 1.5 ml of 10 mM Tris\HCl (pH 7.4)\1 mM PMSF\5 mM EDTA\1 % SDS (SDS solubilization buffer), homogenized and incubated for 20 min at room temperature to ensure solubilization of the receptors with a maximal yield (approximately 85 %). Then cell lysates were centrifuged at 14000 g for 20 min at 15 mC.
Photolabelled proteins were separated by SDS\PAGE (10 % gel) under denaturing conditions according to Laemmli's protocol [20] . Gels were fixed in a methanol\glycerol\water mixture (20 : 1 : 79, by vol.), dried and exposed to Kodak XAR-5 film at k80 mC.
Immunoprecipitation of photolabelled receptors
COS-7 cells grown on 15-cm plates were washed twice with PBS and then homogenized in 1.5 ml of 10 mM Tris\HCl (pH 8)\1 mM PMSF\5 mM EDTA\137 mM NaCl\10 % glycerol\ 1 % Triton X-100 (Triton solubilization buffer). Homogenates were incubated at room temperature for 20 min to ensure optimal solubilization of the receptors (receptor solubilization yield approx. 60 %), then centifuged at 14000 g for 20 min. Solubilized COS-7 cell extracts (500 µl) containing receptors photolabelled with ["#&I]Sar",(4h-N $ )Phe)-AII were incubated overnight at 4 mC with a monoclonal anti-c-Myc antibody 9E10 [14] (10 µl of ascites fluid), then for 2 h at 4 mC with 100 µl of a suspension of Protein A-Sepharose beads (2 mg of Protein A\ml of Sepharose beads ; Sigma). The sedimented beads were washed three times with 1 ml of cold Triton solubilization buffer, then resuspended in 100 µl of Laemmli buffer and heated at 100 mC for 5 min. Samples were analysed on a 10 % polyacrylamide gel. Immunoprecipitation yields were estimated from the radioactivities in gel slices corresponding to the covalent receptor complexes.
Immunoblotting
Transfected cells grown in 15-cm plates were washed twice with PBS (pH 7.4) and solubilized in 1.5 ml of SDS solubilization buffer, as indicated for the photolabelling experiments. The cell lysates were submitted to SDS\PAGE (10 % gel) and proteins were transferred to a nitrocellulose membrane (0.45 µm ; BioRad) in 25 mM Tris\192 mM glycine\20 % methanol. The nitrocellulose membrane was incubated overnight at 4 mC with an anti-c-Myc antibody 9E10 (dilution 1 : 100 of ascites fluid) in 50 mM Tris\HCl\150 mM NaCl\0.5 mg\ml sodium azide\10 % low-fat milk (pH 7.4 ; Tris-buffered saline, or TBS buffer). After washing, the membrane was incubated for 1 h at room temperature with anti-mouse IgG antibody (1 : 4000 dilution) coupled to peroxidase (Boehringer Mannheim) in TBS buffer containing 0.1 % Tween-20. The membrane was washed and proteins were detected by chemiluminescence using the bioluminescence kit from Boehringer Mannheim.
Enzymic deglycosylation
Transfected cells (1.5i10() were homogenized in 1 ml of 5 mM Tris\HCl\1 mM MgCl # \protease inhibitors : 10 mg\ml leupeptin\20 mg\ml antipain\100 mg\ml benzamidine\10& units of aprotinin (pH 7.4). Homogenates were centrifuged at 100 g for 5 min at 4 mC and the supernatants were centrifuged at 40000 g for 10 min at 4 mC. The protein pellets were solubilized in 1 ml of 5 mM Tris\HCl\1 mM MgCl # \1 % Triton X-100\1 mM PMSF (pH 7.4). Samples (50 µl) containing 50 µg of protein were treated with 1.5 units of peptide-N%-(N-acetyl-β-glucosaminyl)-asparagine amidase (PNGase F ; Genzyme) for 18 h at 32 mC before SDS\PAGE analysis.
Subcellular localization of tagged receptors in COS-7 cells
Transfected cells were grown on glass coverslips. Cells were fixed with 4 % paraformaldehyde in PBS (pH 7.4) for 1 h at room temperature. Fixed cells were washed three times with PBS. Cell permeabilization was carried out by incubating fixed cells for 4 min with 0.2 % Triton X-100 in PBS and washing them three times with PBS. Cells were incubated for 30 min in PBS containing 3 % BSA and incubated overnight with the anti-c-Myc antibody 9E10 (1 : 100 dilution) in PBS containing 0.5 % BSA. After extensive washings, the cells were incubated for 1 h at room temperature with a goat anti-mouse antibody coupled to Rhodamine (1 : 500 dilution ; GamIg TRITC, Nordic) in PBS containing 0.5 % BSA. After three 30-min washes, the cells were rinsed with PBS. Conventional immunofluorescence microscopy was performed using a Zeiss Axiophot microscope equipped with a Zeiss Neofluar 63i1.25 objective.
RESULTS
Expression and pharmacological properties of WT and mutated receptors
The AT " receptor amino acid sequence possesses three potential sites for N-glycosylation (Asn-Xaa-Ser\Thr) : one at the Nterminal end of the receptor (Asn%) and two on the second extracellular loop (Asn"(' and Asn"))). Figure 1 shows the different receptors that we used in this study with combined mutations at the three consensus N-glycosylation sites. All modified receptors were generated on the AT " receptor bearing a sequence encoding a 10 amino acid epitope (c-Myc) at its Cterminal end (myc-C). The receptor lacking the first potential glycosylation site was generated by deleting the first four amino acids, including Asn%, and introducing at the N-terminus an additional c-Myc epitope (myc-N-C). The purpose of this modification was to allow receptor detection from the outside of the cell, the absence of proximate bulky saccharidic chains being liable to favour c-Myc-epitope recognition by a specific antibody. As indicated below, elimination of Asn% and addition the c-Myc epitope at the N-terminus of the receptor had no effect on function and expression of the receptor and allowed efficient receptor detection.
Epitope tagging of the receptor at the N-or C-termini did not modify the binding properties of the receptor, as shown by unchanged dissociation constants (K d ) for ["#&I]Sar"-AII and maximal binding capacities (B max ) of WT and tagged receptors measured on intact transfected COS-7 cells (for details, see Table  1 ). Expression levels of the various constructs were checked after COS-7 cell transfection with variable amounts of cDNA up to 2 µg (Table 1 and Figure 2 ). All the receptors possessing two glycosylation sites were expressed at levels similar to that of the WT receptor. The suppression of two glycosylation sites drastically reduced receptor expression with the exception of the receptor possessing Asn"(' (myc-N-C, Q188) ( Table 1 and Figure  2) , which emphasizes the essential role of this site. The expression level of the fully defective mutant (myc-N-C, Q176,Q188) was only 3 % of the WT receptor (Table 1 and Figure 2 ). These results indicate that the glycosylation site at the Asn"(' residue is sufficient but not necessary for normal expression of the receptor and suggest that N-glycosylation is required for efficient expression of the receptor at the surface of the cell. When binding was detectable, all the defective glycosylation site mutants Table 1 ).
Angiotensin-stimulated IP production of cells transfected with WT and mutant receptors
COS-7 cells were transfected with 100 ng of cDNA of WT, myc-C, myc-N-C, myc-N-C, Q176 and myc N-C, Q188 and 2 µg of cDNA of myc-N-C, Q176,Q188 in order to obtain similar expression levels of the WT and mutant receptors [(2-3)i10& sites\cell]. As shown in Table 1 , the extent of maximal IP production was very similar for WT and mutant receptors when stimulated with Sar"-AII (10 −( M), suggesting that Nglycosylation does not play a significant role in AII-stimulated IP production via receptor coupling to phospholipase C.
Evaluation of carbohydrate addition at the potential Nglycosylation sites by molecular-mass determination of WT and mutant receptors
Analysis of photolabelled receptors by SDS/PAGE and autoradiography
Photoaffinity labelling of WT and mutant receptors were carried out using the iodinated photoreactive probe ["#&I]Sar",(4h-N $ )Phe)-AII. This agonist probe of the AT " receptor has been shown be suitable for specific covalent labelling of the AT " receptor [19] and has been used for molecular-mass determination of AT " receptors from different tissues and species [19, 21, 22] . As shown in Figure 3 , photoaffinity labelling of c-Myc-epitopetagged receptor expressed in COS-7 cells followed by SDS\PAGE and autoradiography analysis led to the detection of a protein with a molecular mass of 153p12 kDa, similar to the WT receptor ( Figure 3A, lanes a and b) . This labelling was specific, and was suppressed when performed in the presence of excess Sar"-AII. The molecular mass of the detected protein, which was much higher than the one calculated from its amino acid sequence [41 kDa (WT receptor)j1.2 kDa (c-Myc epitope)], as well as the breadth of the band, indicated that the AT " receptor was highly glycosylated when expressed in COS-7 cells. The molecular mass of the photolabelled mutant lacking Asn% (myc-N-C) was reproducibly lower than that of myc-C, but the shift could not be accurately estimated due to the low resolution of polyacrylamide gels in the corresponding range of molecular mass ( Figure 3A) . The contribution of Asn% to the shift in molecular mass could more easily be seen for mutants lacking an additional glycosylation site [compare myc-N-C, Q176 and myc-N-C, Q188 with myc-C, Q176 and myc-C, Q188 (Figure 3B)] ; it was estimated to 25-30 kDa. N176Q and N188Q mutations induced decreases in the molecular masses of the photolabelled receptors (85p6 and 80p1 kDa for myc-N-C, Q176 and myc-N-C, Q188 mutants respectively ; Figure 3B ), indicating that Asn"(' and Asn")) are sites for carbohydrate addition. Taken together these data demonstrate that each of the three potential N-glycosylation sites is utilized in COS-7 cells.
As the fully glycosylation-defective mutant (myc-N-C, Q176,Q188) was poorly expressed at the plasma membrane, its molecular mass could not be evaluated through photolabelling and autoradiography. 
Immunoblotting detection of WT and mutant receptors
Single tagging (N-or C-terminal) of the AT " receptor did not allow its efficient detection through SDS\PAGE analysis of COS-7 cell extracts and immunoblotting. However, the epitopetagged receptors solubilized in 0.1 % Triton X-100 detergent could be immunoprecipitated with anti-c-Myc antibodies adsorbed on Protein A-Sepharose beads, with a yield of 40 % (results not shown). These results indicate that the epitope was not easily accessible when the protein was denatured in SDS and transferred to nitrocellulose membrane. Double tagging of the receptor (myc-N-C) not only increased the yield of receptor immunoprecipitation up to 60 % (results not shown), but also increased the sensitivity of immunoblotting detection. Thus only receptors bearing the epitope at the two N-and C-terminal ends (lacking Asn%) were analysed by Western blotting. As shown in Figure 4 , two major bands were detected by the c-Myc antibody for myc-N-C, myc-N-C, Q176 and myc-N-C, Q188 : low-molecular-mass forms (35-43 kDa), present in the three mutants, and higher-molecular-mass forms with sizes varying with the analysed receptor. As shown in Figure 4 (lane a), the staining was specific for the c-Myc epitope ; no band was detected in cell extract containing the WT receptor. The high-molecular-mass bands detected by the c-Myc antibody corresponded to those detected by receptor photolabelling ; they probably represented molecular forms of receptors that had reached the plasma membrane and were accessible to labelling on intact cells. As already found in photolabelling experiments (Figure 3) , a shift of these immunodetected bands was observed for the N176Q and N188Q mutants (Figure 4, lanes c and d) , confirming that Asn"(' and Asn")) bear carbohydrate chains. The low-molecular-mass band was heterogeneous except for the case of the fully defective glycosylation-site mutant (myc-N-C, Q176,Q188 ; Figure 4 , lane e), this latter was characterized by a 35 kDa entity corresponding to the lower-molecular-mass component detected for the other mutants ( Figure 4, lanes b, c and d) . This band is characteristic of the fully deglycosylated receptor, as it was not significantly shifted upon PNGase F treatment ( Figure 5, lane b) ; it was obtained through enzymic treatment of the glycosylated receptor ( Figure 5, lane a) . One must notice that this value is significantly lower than expected from the amino acid sequence of the tagged receptor (41 kDa and 1.8 kDa for the AT " receptor and c-Myc epitope, respectively). Such a difference between theoretical and experimental molecular masses has already been observed for angiotensin receptors [23] [24] [25] and histamine H # receptors [26] . Besides a possible inaccurate estimation of molecular masses by SDS\PAGE, one cannot exclude proteolysis of the receptor, which might be facilitated in the absence of N-linked sugars and would agree with the well-known protecting role of saccharidic chains [27, 28] . Such a hypothesis would imply the loss of one of the two c-Myc epitopes ; immunoblotting detection in this situation would be facilitated by increased accessibility of the remaining epitope, as compared with the detection of the glycosylated receptor, which required both tags.
Surprisingly, in some experiments a 64p5 kDa molecularmass band was detected in cellular extracts prepared from cells expressing the receptor lacking the three consensus Nglycosylation sites (myc-N-C, Q176,Q188 ; Figure 4 , lane e). One can speculate that this band corresponds to aggregated forms of the receptor (its size is consistent with that of a dimer) ; this hypothesis is supported by data reporting the existence of multimeric forms of GPCR resistant to denaturing conditions [29] [30] [31] . The very-high-molecular-mass bands detected for other mutants might reflect the presence of aggregated forms of fully or partially glycosylated receptors.
Subcellular localization of WT and N-glycosylation-site-defective receptors
In order to verify the fate of mutant receptors that could not be detected through radioligand binding, their expression was checked in intact COS-7 cells by indirect immunostaining using a monoclonal anti-c-Myc antibody and a Rhodamine-labelled anti-mouse antibody. Staining of COS-7 cells transfected with the receptor bearing the c-Myc epitope at its C-terminus was only visible when they were permeabilized ( Figure 6, row 2) . The intracellular staining, localized at the inner face of the plasma membrane and inside the cell, was specific, as shown by its absence on cells transfected with the WT receptor ( Figure 6 , row 1). As expected, the same pattern was obtained with cells transfected with receptor tagged at both ends (myc-N-C ; Figure  6B , row 3). However, this latter could be detected from the outside without cell permeabilization ( Figure 6A, row 3) . These results indicate that the receptor lacking the Asn% residue was normally expressed at the plasma membrane, thus confirming the ["#&I]Sar"-AII-binding experiments. As shown in Figure 6 , receptors mutated at both Asn"(' and Asn")) (myc-C, Q176,Q188) or lacking the three consensus glycosylation sites (myc-N-C, Q176,Q188) were not detected on the surface of nonpermeabilized cells, but could be stained inside permeabilized cells. These data are in agreement with the very low or undetectable ["#&I]Sar"-AII binding (see binding experiments, Table  1 ), demonstrating that these mutants displayed impaired trafficking to the plasma membrane. Although the identification of the stained intracellular compartments requires further studies, the perinuclear localization of these mutants suggests that they might be sequestered to the endoplasmic reticulum.
DISCUSSION
The role of N-glycosylation in the pharmacological properties and expression of GPCR has been investigated for some members of this family [26, [32] [33] [34] [35] [36] [37] [38] [39] . As do most heptahelical receptors, the rat AT "a AII receptor possesses several potential consensus sites for N-glycosylation [6, 9] , one located at the N-terminus (Asn%) and two located in the second extracellular loop (Asn"(' and Asn"))). A preliminary study of Yamano et al. [13] reported that individual mutations of these sites had no effect on receptor function. The purpose of the more detailed mutagenesis study reported in the present work was to investigate the role of Nlinked saccaridic chains on receptor functions : expression at the plasma membrane, AII recognition and phospholipase Ccoupling properties. The work involved photaffinity labelling, and epitope tagging of the WT and mutant receptors for their detection through immunoblotting and immunocytochemical cellular localization. All the mutants were generated on a receptor bearing a 10 amino acid c-Myc epitope at the C-terminal end of the receptor. Asn"(' and Asn")) were mutated into Gln while Asn% was removed by deleting the first four amino acids and replacing them with an additional c-Myc sequence. This double tagging was shown to amplify the sensitivity of receptor immunodetection by Western blotting. The introduction of these tags, including N-terminal tagging associated with Asn% suppression, did not modify ["#&I]Sar"-AII binding, phospholipase C coupling or processing properties of the receptor. SDS\PAGE analysis of photolabelled receptors and immunoblotting detection together with enzymic deglycosylation demonstrated that the three potential N-glycosylation sites actually bear carbohydrate chains in COS-7 cells, as assessed by the striking changes in the molecular masses of mutant receptors. An extensive analysis of the properties of mutant receptors lacking one or several glycosylation sites allowed us to draw conclusions about the requirements for normal expression. N-glycosylation is required for receptor expression at the plasma membrane as the receptor lacking the three sites could be detected neither by ligand binding nor by immmunocytochemical detection in non-permeabilized intact cells. We also demonstrated that the presence of two sites, irrespective of their localization, allowed an expression level similar to that of the WT receptor. Interestingly, only the preservation of Asn"(' insured optimal expression. The same was not found for Asn% and Asn")), demonstrating that the roles of the saccharidic chains at the various sites are not equivalent. All the mutant receptors that were expressed at the plasma membrane displayed unchanged pharmacological properties (K d for "#&I-Sar"-AII binding ; Sar"-AII-induced IP production) as compared with the WT receptor.
Epitope tagging has allowed us to monitor the cellular localization of the various receptors. The validity of the strategy and experimental conditions can be verified ; N-terminal tagging with the c-Myc epitope proved to be appropriate for the specific detection of expressed receptors from the outside of the cell, whereas intracellular receptors were detected in permeabilized cells. We confirmed that mutant receptors that were undetectable by ligand binding to intact cells were not expressed at the plasma membrane ; moreover they were normally detected intracellularly, indicating that their biosynthesis was not affected by glycosylation-site suppression. The immunochemical staining was more concentrated near the nucleus, suggesting that the protein accumulates in the endoplasmic reticulum of the cell. As a consequence, the lack of delivery of some glycosylation-deficient mutants can be interpreted as resulting from their impaired folding. Indeed, the role of N-glycosylation on protein maturation has been documented widely and a folding process based on the binding of the lectins calnexin and calreticulin to the newly synthesized glycoprotein has been described [40, 41] . Although calnexin-dependent and -independent mechanisms have been postulated to participate in the conformational maturation of the vasoactive intestinal peptide 1 receptor [35] , studies on the relationships between N-glycosylation and molecular chaperones, such as lectins present in the ER, remain to be extended to other GPCRs. Up to now, a general role for Nglycosylation within this family has not been clarified. Whereas N-glycosylation requirements for the trafficking of the β # adrenergic receptor [32] [33] [34] , vasoactive intestinal peptide 1 receptor [35] , rhodopsin [36] and gonadotropin-releasing hormone receptor [37] have been reported, N-glycosylation is not essential for the processing of m # muscarinic receptor [38] , histamine H # receptor [26] or parathyroid receptor [39] . The role of Nglycosylation in the AT " -receptor trafficking might explain the difficulties we encountered for its expression in SF9 insect cells (D. Solier, J. C. Bonnafous and J. Marie, unpublished work) and Escherichia coli (B. Bertin, J. Marie and D. Strosberg, personal communication), which are cell systems in which oligosaccharide processing is lacking (E. coli) or differs from that of mammalian cells (SF9 cells) ( [42] and references cited therein). The difficulty of expressing functional receptors in E. coli could be overcome by forcing their accumulation in inclusion bodies and reconstituting them in lipid vesicles, as shown by an elegant study of an olfactory receptor [43] . Nevertheless, the development of eukaryotic systems for GPCR overexpression appears the most straightforward, as shown for rhodopsin [44] . The development of overexpression and purification systems [42] remains, to date, a challenge for most of the laboratories working on structure-function relationships of GPCRs, including their physicochemical or biophysical characterization. In this respect, the present work constitutes a prerequisite for future structural studies, inasmuch as it has delineated a set of receptor constructs that allow preservation of expression properties and are adapted to their purification using c-Myc antibodies.
